Leerink Partners Cuts Price Target as Fluidigm (FLDM) Announces 4Q Chip Launch
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Fluidigm Announces New Integrated Fluidic Circuits for Single-Cell Genomics on the C1 System
April 12, 2016 8:44 AM EDTSOUTH SAN FRANCISCO, Calif., April 12, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM) today announced new integrated fluidic circuits (IFCs) that will increase the number of single cells that can be isolated and analyzed on the C1 system. Bringing together the trusted Fluidigm® C1 single-cell isolation system with the benefits of a growing suite of optimized microfluidic circuits, researchers can confidently expand their single-cell studies while taking advantage of well-established, industry-proven workflows.
Single-cell research is fast becoming a technology standard in basic and translational research, biomarker discovery, and therapeutic development. Using single-cell approaches, researchers are... More
